{"id":"NCT04549168","sponsor":"Eisai Co., Ltd.","briefTitle":"A Study of Lemborexant in Chinese Participants With Insomnia Disorder","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of the Efficacy and Safety of Lemborexant in Chinese Subjects With Insomnia Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-11-06","primaryCompletion":"2023-03-17","completion":"2023-03-17","firstPosted":"2020-09-16","resultsPosted":"2024-12-20","lastUpdate":"2024-12-20"},"enrollment":194,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Sleep Initiation and Maintenance Disorders"],"interventions":[{"type":"DRUG","name":"Lemborexant","otherNames":["E2006"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Lemborexant 10 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The primary purpose of this study is to confirm using polysomnography (PSG) that lemborexant 10 milligram (mg) is superior to placebo on objective sleep onset as assessed by latency to persistent sleep (LPS) during the last 2 nights of 1 month of treatment in participants with insomnia disorder.","primaryOutcome":{"measure":"Change From Baseline of Mean Latency to Persistent Sleep (LPS) Over the Last 2 Nights of 1 Month of Treatment of Lemborexant 10 mg Compared to Placebo","timeFrame":"Baseline, Days 29 and 30","effectByArm":[{"arm":"Randomization Phase: Placebo","deltaMin":-21.71,"sd":42.809},{"arm":"Randomization Phase: Lemborexant 10 mg","deltaMin":-39.47,"sd":46.147}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0585"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":23,"countries":["China","Taiwan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":194},"commonTop":["COVID-19","Influenza","Upper respiratory tract infection","Hyperlipidaemia","Thrombocytopenia"]}}